Showing posts with label prescription drugs. Show all posts
Showing posts with label prescription drugs. Show all posts

Wednesday, June 19, 2013

Shocking stat shows nearly 70 percent of Americans on at least one prescription drug

Photo: Daniel Rizzuti/freedigitalphotos.net
In a study that shows our shocking dependence on big pharma, the Mayo Clinic today reports that nearly 70 percent of Americans are on at least one prescription drug, and more than half take two.

Antibiotics, antidepressants and painkilling opioids are most commonly prescribed, their study found. Twenty percent of patients are on five or more prescription medications, according to the findings, published online in the journal Mayo Clinic Proceedings.

Researchers find the data valuable because it gives insight into prescribing practices. The statistics from the Rochester Epidemiology Project in Olmsted County, Minn. are comparable to those elsewhere in the United States, says study author Jennifer St. Sauver, Ph.D., a member of the Mayo Clinic Population Health Program in the Mayo Clinic Center for the Science of Health Care Delivery.

"Often when people talk about health conditions they're talking about chronic conditions such as heart disease or diabetes," Dr. St. Sauver says. "However, the second most common prescription was for antidepressants — that suggests mental health is a huge issue and is something we should focus on. And the third most common drugs were opioids, which is a bit concerning considering their addicting nature."

Seventeen percent of those studied were prescribed antibiotics, 13 percent were taking antidepressants and 13 percent were on opioids. Drugs to control high blood pressure came in fourth (11 percent) and vaccines were fifth (11 percent). Drugs were prescribed to both men and women across all age groups, except high blood pressure drugs, which were seldom used before age 30.

Overall, women and older adults receive more prescriptions. Vaccines, antibiotics and anti-asthma drugs are most commonly prescribed in people younger than 19. Antidepressants and opioids are most common among young and middle-aged adults. Cardiovascular drugs are most commonly prescribed in older adults. Women receive more prescriptions than men across several drug groups, especially antidepressants: Nearly 1 in 4 women ages 50-64 are on an antidepressant.

For several drug groups, use increases with advancing age.

"As you get older you tend to get more prescriptions, and women tend to get more prescriptions than men," Dr. St. Sauver says.

Prescription drug use has increased steadily in the U.S. for the past decade. The percentage of people who took at least one prescription drug in the past month increased from 44 percent in 1999-2000 to 48 percent in 2007-08. Spending on prescription drugs reached $250 billion in 2009 the year studied, and accounted for 12 percent of total personal health care expenditures. Drug-related spending is expected to continue to grow in the coming years, the researchers say.

The study was funded by the National Institute on Aging and the Mayo Clinic Center for the Science of Health Care Delivery.

--------------------------------------------------------------------------
Improve your health by improving the quality of the air your breathe. Remove asthma and allergy triggers as well as airborne chemicals with a high quality air cleaner. AllerAir Air Purifiers remove 99.97% of airborne dust, particles and the chemicals and odors that other air cleaners leave behind. Connect with us to learn more www.allerair.com.

Wednesday, April 10, 2013

Doctors not informed of harmful effects of drugs by pharma reps

Photo: Daniel Rizzuti
The majority of family doctors receive little or no information about harmful effects of medicines when visited by drug company representatives, according to an international study involving Canadian, U.S. and French physicians.

Yet the same doctors indicated that they were likely to start prescribing these drugs, consistent with previous research that shows prescribing behaviour is influenced by pharmaceutical promotion.

The study, which had doctors fill out questionnaires about each promoted medicine following sales visits, was published online today in the Journal of General Internal Medicine. It shows that sales representatives failed to provide any information about common or serious side effects and the type of patients who should not use the medicine in 59 per cent of the promotions. In Vancouver and Montreal, no potential harms were mentioned for 66 per cent of promoted medicines.

"Laws in all three countries require sales representatives to provide information on harm as well as benefits," says lead author Barbara Mintzes of the University of British Columbia. "But no one is monitoring these visits and there are next to no sanctions for misleading or inaccurate promotion."

Serious risks were mentioned in only six percent of the promotions, even though 57 per cent of the medications involved in these visits came with US Food and Drug Administration "black box" or Health Canada boxed warnings – the strongest drug warning that can be issued by both countries.

"We are very concerned that doctors and patients are left in the dark and patient safety may be compromised," says Mintzes, an expert on drug advertising in UBC's School of Population and Public Health.

Doctors in Toulouse were more likely to be told of a harmful effect in a promotional visit, compared to doctors in Canada and the U.S., according to the study. Researchers suggested that this may reflect stricter regulatory standards for promotion of medicines in France.
 -----------------------------------------------------------------------------------------
Improve your health by improving your indoor air quality. AllerAir Air Purifiers remove 99.97% of airborne dust, particles and the chemicals and odors that other air cleaners leave behind.

Thursday, March 29, 2012

Experts probe possible link between asthma inhalers and birth defects

An inquiry will look at prescription
drug usage during pregnancy.
A Europe-wide study will be following thousands of pregnant women taking prescription drugs for asthma, epilepsy, diabetes and depression to see if there is an increased risk of birth defects and health problems in babies.

The study will examine nearly four million births and concentrate in asthma inhalers, man-made insulin, new anti-epileptics and Prozac-style anti-depressants called SSRIs, which many pregnant women with chronic conditions need to take even during pregnancy.

The researchers urged pregnant women to keep taking their medications and to talk to their health care providers if they are worried.

Traditionally, women have been cautioned to be careful with drugs during pregnancy because it is very difficult to establish safety in pregnancy.

Some prescription drugs have already been linked to birth defects or health problems, including preventive asthma inhalers, which can increase the risk of hormonal and metabolic disorders in infants.

Doctors say that risks need to be weighed with the benefits of taking medications and that more research is needed to determine the risks.

Source: The Daily Mail

Find relief with better indoor air quality

Women and others suffering from asthma and respiratory diseases can benefit from breathing cleaner and fresher air.
AllerAir air purifiers clean the air with activated
carbon and HEPA air filters.

The best ways to improve indoor air quality are source control (avoid adding pollutants to the indoor environment as much as possible), ventilation (open windows, maintain ventilation system) and air cleaning (a high-quality air purifier with activated carbon and HEPA can remove the widest range of pollutants).

Many indoor air contaminants are known to cause or aggravate asthma symptoms as well as other health effects.

AllerAir offers the most efficient and long-lasting air purifiers for asthma and allergies with a deep-bed activated carbon filter as well as a HEPA filter and optional UV germicidal filtration.

The AirMedic Series includes AllerAir’s best air purifiers for particle concerns, while the 5000 Exec also provides superior protection.

For more information, contact AllerAir.